Generic cholesterol drug shows promise in early comparison

NCT ID NCT07170852

Completed Knowledge-focused Sponsor: Humanis Saglık Anonim Sirketi Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested whether a generic bempedoic acid tablet works the same as the brand-name drug Nilemdo in 32 healthy adults. Participants took a single dose of each under fasting conditions, and researchers measured drug levels in the blood. The goal was to see if the generic is absorbed similarly, which could lead to a more affordable option for managing high cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bempedoic acid
What this could lead to: If successful, this could help bring a lower-cost generic version of bempedoic acid to market for managing high cholesterol.
What could go wrong: This is a small, early-phase study in healthy volunteers, not patients. It only checks if the generic is absorbed similarly, not if it actually lowers cholesterol or prevents heart problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hypercholesterolemia, familial, 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERCHOLESTEROLAEMIA

Contacts and locations

Locations

Cliantha Research Limited

Noida, 201301, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.